Innospec (IOSP) Q3 2026: Earnings Beat Driven by an 84% Surge in Performance Chemicals
As seen on the 24/7 Wall St. homepage on November 3, 2026.
Performance Chemicals operating income jumped 84% to $16.9 million, carrying the earnings beat even as revenue missed expectations. The board also lifted the semi-annual dividend to 94 cents.
Continue ReadingShow less
Innospec reported adjusted earnings per share of $1.29 for the third quarter of 2026, edging past the consensus estimate of $1.26 by about 2.4%. Revenue of $473.6 million came in just below the expected $479.2 million, a miss of roughly 1.2%, though it still represented a 7.2% increase from the same period a year ago. The result continues a streak in which Innospec has beaten or matched EPS estimates in every quarter shown in the company's recent history.
The clearest driver of the earnings beat was Performance Chemicals, where operating income jumped 84% to $16.9 million. A 12% tailwind from positive price and product mix more than offset a 5% volume decline and a 1% negative currency impact, lifting the segment's gross margin by 3.7 percentage points to 18.8%. Management pointed to continued progress on new products and plans to commission plant efficiency upgrades at a North Carolina facility by year-end, which are expected to expand capacity, productivity, and yields across personal care and other product lines.
Oilfield Services also stood out, with operating income rising 40% to $6.7 million following a recent DRA plant expansion. That improvement came despite headwinds: activity delays in the legacy Middle East business and elevated raw material costs kept sequential results below expectations and weighed on gross margin, which fell 1.8 percentage points to 28.2%. CEO Patrick S. Williams said the company expects improvement across several of those pressure points to drive sequential operating income growth in the fourth quarter.
Sponsored
One softer note in the quarter was operating cash flow, which dropped to $17.4 million from $39.1 million a year earlier, with working capital absorbing $87.4 million on a year-to-date basis. Adjusted EBITDA improved to $51.4 million from $44.2 million. The company's net cash position remained above $250 million, giving management flexibility it described as available for organic investment, acquisitions, dividend growth, and buybacks.
The board approved a semi-annual dividend of 94 cents per share, bringing the annual dividend to $1.86, a 9% increase over 2025. R&D spending rose to $16.8 million from $13.7 million a year ago, reflecting investment behind the Performance Chemicals pipeline. The adjusted effective tax rate ticked up to 24.7% from 22.7%, a headwind attributed to the geographic mix of taxable profits.
Mentioned: IOSP